p.kravchenko
Submits third-party assay reports on material purchased directly. Based in Bursa.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
98.84%
n=10
Suppliers covered
8
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041913 | Ipamorelin | SinoPep | SNP-2606-L4478 | PeptideMeter | 2026-Q3 | 98.88 | 5.28 | — | Buyer-sourced | 0 | FAIL |
| AX-2026-043533 | GHRP-2 | SIG | SIG-2603-6031 | Janoshik | 2026-Q3 | 98.51 | 1.13 | 92.1 | Buyer-sourced | 0 | FAIL |
| AX-2026-043149 | Semax | SSA | SSA-2604-L7739 | Janoshik | 2026-Q2 | 98.39 | 8.45 | — | Buyer-sourced | 0 | FAIL |
| AX-2026-042451 | Semaglutide | Homopeptide | HOMO-2511-C4492 | VendorInvestigate | 2026-Q1 | 98.78 | 5.01 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042846 | Tirzepatide | GGPeps | GGPE-2510-L2662 | Medutest | 2026-Q1 | 99.07 | 4.00 | — | Supplier-supplied | 0 | PASS |
| AX-2025-018725 | SS-31 (Elamipretide) | QSC | QSC-2502-M6829 | PeptideMeter | 2025-Q3 | 98.20 | 5.32 | 107.5 | Buyer-sourced | 1 | FAIL |
| AX-2025-020734 | Triptorelin | SGN | SGN-2504-A9334 | Medutest | 2025-Q2 | 98.81 | 4.98 | 103.8 | Buyer-sourced | 0 | PASS |
| AX-2025-019212 | Tirzepatide | SinoPep | SNP-2502-X4903 | Janoshik | 2025-Q2 | 98.95 | 6.85 | 101.4 | Buyer-sourced | 0 | PASS |
| AX-2025-019663 | Afamelanotide | TFC | TFC-2502-Y2346 | Janoshik | 2025-Q1 | 99.28 | 5.01 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019608 | GHRP-2 | TFC | TFC-2411-A2083 | Janoshik | 2025-Q1 | 99.72 | 2.09 | — | Buyer-sourced | 0 | PASS |